BICO Group logo

BICO Group(OTC) BCCOY

Market Cap$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-98%
5 YearN/A
1 Year-54%
1 Month+0%
$0.37
+0.00%
+0.00Today
BICO Group last closing stock price
MetricPriceDate
Last closeUSD 0.372026-08-14
BICO Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.372026-07-28
1 month+0%USD 0.372026-07-15
3 month-43.26%USD 0.652026-05-15
Year to date-33.61%USD 0.562025-12-29
1 year-53.9%USD 0.802025-07-22
3 year-58.79%USD 0.892023-08-08
Since inception-97.51%USD 14.802021-09-29

BICO Group Financials at a Glance

Market Cap

$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.50B

Net Income (TTM)

-SEK 830.67M

EPS (TTM)

-$0.31

P/E Ratio

-1.17

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.37

Volume

20

Open

$0.37

Previous Close

$0.37

Daily Range

$0.37 - $0.37

52-Week Range

$0.35 - $0.75

Estimated Earnings Date

Apr 27, 2026

BCCOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BICO Group

BICO Group AB (publ) is a leading bio-convergence company based in Gothenburg, Sweden, specializing in advanced bioprinting and bioautomation technologies. Founded in 2016, the company operates globally, providing innovative solutions to the medical, pharmaceutical, and cosmetic industries.

Products and Services
  • 3D bioprinters and hybrid microscopes for laboratory applications
  • Precision dispensing and biosensor technologies for industrial clients
  • Advanced robotics and diagnostics automation solutions
Growth Outlook
  • Revenue increased to SEK 346.5 million in Q2 2026, up from SEK 329.9 million in Q1 2026
  • Gross profit margin improved to 46.8% in Q2 2026, indicating operational efficiency
  • Strong international presence supports expansion into new markets
Financial Highlights
  • Trailing twelve months (TTM) revenue of SEK 1.4 billion, reflecting robust demand
  • Current ratio of 2.42, indicating strong liquidity position
  • Net income for Q2 2026 was SEK -38.3 million, showing ongoing investment in growth
BICO Group AB (publ) is positioned at the forefront of the bio-convergence sector, combining biotechnology and engineering to create innovative solutions. The company's Laboratory Solutions division offers cutting-edge scientific equipment and consumables, while the Bioautomation segment focuses on precision technologies for industrial applications. Recent financial performance indicates a positive trend, with revenue growth and improved gross profit margins. The company's strong liquidity position, as evidenced by a current ratio of 2.42, supports its ongoing investments in research and development. With a commitment to expanding its global footprint, BICO Group AB (publ) is well-positioned to capitalize on the growing demand for bioprinting and bioautomation technologies.
AI Generated • Aug 23, 2026

Industry

Life Sciences Tools and Services

Employees

602

CEO

Maria Ada Eufemia Forss, MBA

Website

bico.com

Headquarters

Gothenburg, VG 412 63, SE

BCCOY Financials

Key Financial Metrics (TTM)

Gross Margin

45.61%

Operating Margin

-11.37%

Net Income Margin

-55.79%

Return on Equity

-49.84%

Return on Capital

-7.28%

Return on Assets

-29.64%

Earnings Yield

-85.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

276.30M

Volume

20

Avg. Volume

3.54

Financials (TTM)

Gross Profit

SEK 684.75M

Operating Income

-SEK 171.37M

EBITDA

-SEK 995.96M

Operating Cash Flow

SEK 7.90M

Capital Expenditure

-SEK 17.45M

Free Cash Flow

-SEK 9.55M

Cash & ST Invst.

SEK 626.02M

Total Debt

SEK 684.97M

BICO Group Performance Analysis

BICO Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 209,567,42543.1%
20232023-12-31SEK 189,375,529-9.6%
20242024-12-31SEK 163,363,659-13.7%
20252025-12-31SEK 152,658,541-6.6%
BICO Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3017.6%
Q42025-12-3116.0%
Q12026-03-31-25.4%
Q22026-06-305.0%
BICO Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -0.30180.7%
20232023-12-31SEK -0.3929.1%
20242024-12-31SEK -0.00-99.5%
20252025-12-31SEK -0.3921750.0%
BICO Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3096.3%
Q42025-12-3190.5%
Q12026-03-31-124.4%
Q22026-06-3070.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 346.49M

+6.9%

Gross Profit

SEK 162.26M

+13.9%

Gross Margin

46.83%

N/A

Market Cap

$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$146.62K

N/A

Employees

695

N/A

Net Income

-SEK 38.35M

+79.2%

EBITDA

SEK 13.50M

+130.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 626.02M

+837.6%

Total Debt

SEK 684.97M

-51.3%

Accounts Receivable

SEK 281.29M

+790.9%

Inventory

SEK 207.18M

-11.3%

Long Term Debt

SEK 625.32M

+151.7%

Short Term Debt

SEK 59.65M

-94.8%

Return on Assets

-29.64%

N/A

Return on Invested Capital

-7.30%

N/A

Free Cash Flow

-SEK 65.00M

-91.2%

Operating Cash Flow

-SEK 59.05M

-109.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NDTPNDT Pharmaceuticals Inc.
$0.42+0.00%
MLLCFMolecular Partners AG
$4.01+0.00%
CYBQFCYBERDYNE Inc.
$1.31+0.00%
YOURFYourWay Cannabis Brands Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About BCCOY

What is the current price of BICO Group?

BICO Group is trading at $0.37 per share.

What is the 52-week range for BICO Group?

Over the past 52 weeks, BICO Group has traded between $0.35 and $0.75.

How much debt does BICO Group have?

As of the most recent reporting period, BICO Group reported total debt of SEK 70.95M.

How much cash does BICO Group have on hand?

BICO Group reported SEK 64.85M in cash and cash equivalents in its most recent financial results.

What is BICO Group’s dividend yield?

BICO Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.